'iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, announced it has initiated a clinical study for Colon CAD, its virtual colonoscopy CAD product, in partnership ...'

'Definiens, the number one Enterprise Image Intelligence? company, announced the introduction of a new multi-dimensional image analysis platform. Software applications built on Definiens XD extract previously unattainable levels of volumetric ...'

'NEW ORLEANS, La.?As many as 50 percent of all cardiac deaths due to disease in the heart's vessels occur in individuals with no prior history or symptoms of heart disease. In addition, standard coronary risk factors may fail to explain up to 50 percent ...'

'ScienceDaily (Jun. 10, 2008) ? Researchers at UCLA's Jonsson Comprehensive Cancer Center have modified a common chemotherapy drug to create a new probe for Positron Emission Tomography (PET), an advance that will allow them to model and measure the ...'

'Chest x-ray (CXR) is the most common radiographic procedure. It is the upper part of the trunk or known as thorax, situated between neck and abdomen. For imaging purposes, it was divided into three parts which are the bony thorax, the respiratory system ...'

'Cross-use of technology between nuclear medicine and radiology technologists is expanding. The growth of PET/CT and the increasing use of intravenous contrast agents during these procedures bring the nuclear medicine technologist into direct contact ...'

'What kind of scanner should you use to plan complex implants? In a shoot-out between multislice computed tomography (MSCT) and small-field cone-beam CT (CBCT), both imaging modalities lived to see another ...'

'Extremely low dose CT coronary angiography can be used to measure cardiac function and has the potential for use when other commonly used examinations are limited, a preliminary study indicates. "CT coronary angiography provides a wealth of data ...'

'FluoroPharma Inc., a company developing breakthrough cardiovascular molecular imaging agents for the Positron Emission Tomography (PET) market, announced commencement of Phase I clinical trials for BFPET, following institutional review board (IRB) ...'

'Cancer imaging technology company Michelson Diagnostics Ltd (MDL) has announced that it has commenced the engineering phase of its development of probes for in-vivo imaging with optical coherence tomography (OCT). According to MDL Applications ...'